Phase 1 CKD Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)

Regend Therapeutics15 enrolled1 locationNCT07275788

Recruiting

Phase 1

A Study to Evaluate the Safety, Tolerability and PK of SK-08

Chronic Kidney Disease(CKD)

Consun Pharmaceutical Group48 enrolled1 locationNCT07021157

Recruiting

Phase 1Phase 2

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

CystinosisCKD Stage 4FSGS+2 more

Alice Bertaina12 enrolled1 locationNCT05508009